Email not displaying correctly? View it in your browser

DNDi and Cipla collaborate on a 4-in-1 ARV combination for paediatric HIV
On the eve of the 19th International AIDS Conference in Washington, DC, DNDi and Cipla announced their collaboration to develop a new 4-in-1 ARV combination for infants and toddlers living with HIV.
Read more

Listen to the podcast by Rachel Cohen, Regional Executive Director, DNDi North America on DNDi's paediatric HIV project (3 min 40) 
International AIDS Conference Symposia, Washington DC, 22 July 2012
DNDi co-organized a satellite session with the International AIDS Society-Industry Liaison Forum, which stressed the oft-neglected drug development needs of young children with HIV. Another satellite was organized with MSF and Health GAP on sustainable financing and coordination of research to ensure innovation for and access to HIV and TB treatments.
 Read more

Publications: DNDi 2011 Annual Report and new brochure are out!

Through its 2011 Annual Report, DNDi highlights its main R&D milestones and provides comprehensive information about the organization’s performance and accomplishments in the field of neglected diseases.
 Read more    

In this new brochure, read in layman’s terms what we do and how we work.
Read more
Azoles E1224 for Chagas disease: Completion of the study recruitment in Bolivia
Two study sites – Cochabamba and Tarija, Bolivia – have completed patient recruitment. A total of 231 patients were included in this Phase II study, which evaluates E1224, a new generation of azole compound, as a new treatment for Chagas disease. 
 Read more  

DNDi in the news

DNDi was mentioned this month in
-IRIN (Paediatric HIV)
-Nature Blog (Paediatric HIV)
-Scidev (NTD research)
-Economic Times of India (R&D Convention)
-Swiss info (Malaria / R&D Convention)
-Swiss info (Malaria / Public Health)